{"id":"placebo-for-k-877","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3545412","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with any biological systems or molecular targets. It is used as a control in clinical trials to compare the efficacy of active treatments.","oneSentence":"This is a placebo, meaning it has no active therapeutic effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:14.204Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control in clinical trials for K-877"}]},"trialDetails":[{"nctId":"NCT06247735","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kowa Research Institute, Inc.","startDate":"2024-02-07","conditions":"Primary Biliary Cholangitis","enrollment":46},{"nctId":"NCT03001817","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function","status":"COMPLETED","sponsor":"Kowa Research Institute, Inc.","startDate":"2016-11-28","conditions":"Severe Hypertriglyceridemia","enrollment":551},{"nctId":"NCT03011450","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment","status":"COMPLETED","sponsor":"Kowa Research Institute, Inc.","startDate":"2016-11-26","conditions":"Severe Hypertriglyceridemia","enrollment":471}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo (for K-877)","genericName":"Placebo (for K-877)","companyName":"Kowa Research Institute, Inc.","companyId":"kowa-research-institute-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo, meaning it has no active therapeutic effect. Used for Control in clinical trials for K-877.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}